- Exhibit & Support
- Hotel & Travel
Newly-approved radiopharmaceuticals often hit the market with little to no information on production, or in-depth guidance on clinical use. Come to this session to hear two experts in the field provides a practical overview of the new FDA-approved radiopharmaceuticals Lutathera and Azedra, and their use in oncology and nuclear medicine.
At the completion of this knowledge-based activity, participants will be able to:
This activity is approved for Board Certified Nuclear Pharmacist (BCNP) recertification credits.